We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
34 result(s) found, displaying 1 to 10
-
Cancellation by sponsorRequested by Eisai Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAYVIGO lemborexant 5 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAYVIGO lemborexant 10 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FYCOMPA perampanel (as hemisesquihydrate) 2 mg/4 mL oral suspension.
-
Prescription medicine registrationActive ingredients: lenvatinib mesilate.
-
Australian Public Assessment Report (AusPAR)New AusPAR for Dayvigo (lemborexant) for the treatment of insomnia.
-
-
Prescription medicine registrationActive ingredients: lemborexant.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Perampanel hemisesquihydrate
-
Designation or determinationPriority review